[Yu Heng Pharmaceutical (002437) (002437)Splinterlandsusers.SZ) realize a net profit of 120 million yuan in 2023SplinterlandsusersTo successfully turn losses into profits]
According to KuaiBao, the performance of Yuheng Pharmaceutical Co., Ltd. (002437.SZ) in 2023, the company's total revenue reached 2.626 billion yuan, down 15.51% from the same period last year. At the same time, the net profit belonging to the shareholders of the listed company was 120 million yuan, successfully turning losses into profits. In addition, after deducting non-recurring profits and losses, the net profit attributable to shareholders of listed companies is 5.Splinterlandsusers, 3.3773 million yuan, and basic earnings per share was 0.0547 yuan.
It can be seen from the report that although the company's total revenue has declined, it has been realized to a certain extent.SplinterlandsusersThe recovery of profitability. This turnaround from loss to profit has undoubtedly injected confidence into the future development of Yuheng Pharmaceutical Industry.
Hexun self-selected Stock Writer risk Tip: the above content is only the views of the author or guest, does not represent any position of Hexun, and does not constitute any investment advice related to Hexun. Before making any investment decision, investors should consider the risk factors related to investment products according to their own circumstances and consult professional investment advisers if necessary. Hexun tries its best but cannot confirm the authenticity, accuracy and originality of the above content, and Hexun does not make any guarantee or commitment.